Parameter | Group 1 | Group 2 | p | Cut-off or Risk factor | Sensitivity % | Specificity % | AUC |
---|---|---|---|---|---|---|---|
Age (years) | 62 (21) | 70 (23.3) | < 0.001a | > 71 | 55.9 | 73.1 | 0.679d |
Sex | Male: 52.0% | Male: 48.0% | 0.005b | Male | 67.3 | 50.3 | 0.774e |
Female: 69.3% | Female: 30.7% | ||||||
Fever (body temperature > 38 °C) | 58.0% | 72.0% | 0.014b | Present | 72.0 | 42.0 | 0.770e |
Dyspnea | 31.9% | 43.8% | 0.082b | ||||
Cough | 49.5% | 50.5% | 0.491b | ||||
Diabetes mellitus | 28.7% | 34.6% | 0.344b | ||||
Hypertension | 42.5% | 57.5% | 0.210b | ||||
Acute renal failure | 1.9% | 3.7% | 0.446c | ||||
Chronic renal failure | 0.4% | 3.8% | 0.001c | Present | 9.4 | 99.3 | 0.863e |
Coronary heart disease | 21.0% | 33.6% | 0.022b | Present | 33.6 | 79.0 | 0.764e |
COPD | 15.3% | 15.0% | 0.941b | ||||
Malignity | 3.2% | 6.5% | 0.199b | ||||
CS treatment at the ward | R: 66.7% | R: 83.8% | 0.009b | Need for CS treatment | 83.78 | 33.33 | 0.595e |
N/R: 33.3% | N/R: 16.2% | ||||||
High dose CS pulse treatment at the ward | R: 30.9% | R: 63.8% | < 0.001b | Need for pulse CS treatment | 63.77 | 69.07 | 0.680e |
N/R: 69.1% | N/R:36.2% |